The American College of Rheumatology's new recommendations aim to help providers and patients achieve the best possible outcomes for people with RA. Regular physical activity is now strongly ...

Understanding the type of arthritis, its causes, and management options is the first step toward living well with the condition.

Advances in biotechnology, a greater understanding of the immunopathogenesis of rheumatoid arthritis (RA) and a desire for more effective therapeutics have led to the development of a class of ...

Rheumatoid arthritis, also known as RA, affects an estimated 1.3 million people in the United States. Beyond this staggering statistic lies a complex reality: each person's experience with RA is ...

Treatments and outcomes for rheumatoid arthritis (RA) have made major advances in the last decade. Earlier diagnoses, better treatment strategies, and improvements in disease modifying anti-rheumatic ...

More than 80% of patients with newly diagnosed rheumatoid arthritis, who were using bridging therapy, successfully tapered off prednisolone at 7 weeks, according to data published in the Annals of the ...

The treat-to-target approach represented a stepped-up model for chronic disease management that only became possible when the available therapies showed the potential for disease remission. The ...

CreakyJoints®, the online, non-profit, arthritis patient support community with more than 80,000 members, today announced the publication of “When patients write the guidelines: Patient panel ...

Clinicians looking for a fresh and authoritative guide to drug treatment for psoriatic arthritis (PsA) can thank the European Alliance of Associations for Rheumatology (EULAR), which just published an ...

Peripheral neuropathy can develop as a complication of rheumatoid arthritis (RA). You may find similar treatments for both, but your doctor is best equipped to determine what medications may work for ...

Monoclonal antibodies (mAbs) are a class of biologic drugs used to treat rheumatoid arthritis if other treatments aren’t effective. mAbs target specific parts of the immune system to reduce ...

Tocilizumab, a repurposed rheumatoid arthritis drug once considered a promising treatment for hospitalized patients with Covid-19, generally did not increase patients' chances of survival or help them ...